Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19678077 | 0.90 | CRHR1 (0.36) | ACHEKDM4EMAPTKMT2A | |
| SCHEMBL3938645 | 0.70 | CA1 (0.39) | ACHEPOLBRECQLKMT2A | |
| SCHEMBL13168482 | 0.66 | ALDH1A1 (0.40) | KDM4EALDH1A1MAPT | |
| SCHEMBL3868257 | 0.65 | ACHE (0.44) | ACHEALDH1A1POLBMAPTKMT2A | |
| SCHEMBL13893748 | 0.65 | — | — | |
| SCHEMBL14462432 | 0.65 | — | — | |
| SCHEMBL13893744 | 0.65 | — | — | |
| SCHEMBL10013789 | 0.64 | ACHE (0.52) | ACHEALDH1A1GAAMAPT | |
| SCHEMBL18853788 | 0.63 | FFAR4 (0.36) | KDM4EALDH1A1 | |
| SCHEMBL13893746 | 0.63 | ALDH1A1 (0.34) | ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170349613-A1 | Method for Depolymerising Oxygenated Polymer Materials | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2017-12-07 | — | — | US | disclosed |
| WO-2016098021-A1 | METHOD FOR DEPOLYMERISING OXYGENATED POLYMER MATERIALS | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349613-A1 | Method for Depolymerising Oxygenated Polymer Materials | PLOD2, DDT, PFAS | ACHE 4/4885KDM4E 271/4885ALDH1A1 1262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.